Action Qualigen Therapeutics - QLGN

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

3,4988

Prix Achat

3,35

Prix Vente

4,30

Volume échangé

57 085

3,135 Fourchette du Jour 3,50

2,96 Plage de 52 semaines 29,435

Cap du marché

2,577M

Clôture Veille

3,27

Ouverture

3,25

Dernière Transaction

350

3.4988

(formt)

Dernière heure de transaction

Volume financier

US$ 190 540

VWAP

3,3378

Volume moyen (3 m)

71 742

Actions en circulation

736 431

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,02

Bénéfice par action (BPA)

-18,22

Chiffre d'affairess

Bénéfice net

-13,42M

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.qualigeninc.com

Siège social

Wilmington, Delaware, USA

Fondé

Qualigen Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker QLGN. Le dernier cours de clôture d'Qualigen Therapeutics était de US$3,27. Au cours de la dernière année, les actions de Qualigen Therapeutics ont été négociées dans une fourchette de prix de US$ 2,96 à US$ 29,435.

Qualigen Therapeutics compte actuellement 736 431 actions en circulation. La capitalisation boursière d'Qualigen Therapeutics est de US$2,41 million. Qualigen Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.02.

Form 8-K - Current report

Qualigen to participate in next funding round for NanoSynex

Market size expected to reach $4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”)announced today they will be the...

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.8012	-18.6325581395	4.3	4.3	2.96	349382	3.31348505	CS
4	-1.0512	-23.1032967033	4.55	4.67	2.96	117321	3.42819541	CS
12	-1.4012	-28.5959183673	4.9	5.046	2.96	71742	3.83784895	CS
26	-6.1012	-63.5541666667	9.6	11.5	2.96	1532006	5.95549201	CS
52	-20.8412	-85.6253081348	24.34	29.435	2.96	3996542	15.5009295	CS
156	-416.5012	-99.166952381	420	760	2.96	1504691	48.999822	CS
260	-3621.5012	-99.9034813793	3625	3950	2.96	1773450	661.78851315	CS

QLGN - Frequently Asked Questions (FAQ)

What is the current Qualigen Therapeutics share price?

The current share price of Qualigen Therapeutics is US$ 3,4988

How many Qualigen Therapeutics shares are in issue?

Qualigen Therapeutics has 736 431 shares in issue

What is the market cap of Qualigen Therapeutics?

The market capitalisation of Qualigen Therapeutics is USD 2,41M

What is the 1 year trading range for Qualigen Therapeutics share price?

Qualigen Therapeutics has traded in the range of US$ 2,96 to US$ 29,435 during the past year

What is the PE ratio of Qualigen Therapeutics?

The price to earnings ratio of Qualigen Therapeutics is -0,02

What is the reporting currency for Qualigen Therapeutics?

Qualigen Therapeutics reports financial results in USD

What is the latest annual profit for Qualigen Therapeutics?

The latest annual profit of Qualigen Therapeutics is USD -13,42M

What is the registered address of Qualigen Therapeutics?

The registered address for Qualigen Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Qualigen Therapeutics website address?

The website address for Qualigen Therapeutics is www.qualigeninc.com

Which industry sector does Qualigen Therapeutics operate in?

Qualigen Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
IVVDInvivyd Inc	US$ 1,055 (194,94%)	448,53M
HCWBHCW Biologics Inc	US$ 0,6265 (125,20%)	344,42M
UOKAMDJM Ltd	US$ 0,2293 (76,38%)	354,09M
GHRSGH Research PLC	US$ 17,9991 (69,80%)	10,31M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 234,64 (61,82%)	392
CYNCYNGN Inc	US$ 0,1169 (-56,70%)	75,52M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,1943 (-54,61%)	327,95M
VIRXViracta Therapeutics Inc	US$ 0,0741 (-51,09%)	9,37M
BOWNUBowen Acquisition Corporation	US$ 3,39 (-49,55%)	17,28k
PITAHeramba Electric PLC	US$ 0,503 (-44,11%)	1,37M
IVVDInvivyd Inc	US$ 1,055 (194,94%)	448,53M
BHATBlue Hat Interactive Entertainment Technology	US$ 0,0462 (27,98%)	434,24M
NVDANVIDIA Corporation	US$ 116,66 (-2,84%)	371,47M
UOKAMDJM Ltd	US$ 0,2293 (76,38%)	354,09M
HCWBHCW Biologics Inc	US$ 0,6265 (125,20%)	344,42M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Qualigen Therapeutics Inc (QLGN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Qualigen Therapeutics Inc

QLGN Dernières nouvelles

Form 8-K - Current report

Qualigen to participate in next funding round for NanoSynex

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Form D - Notice of Exempt Offering of Securities

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Qualigen to participate in next funding round for NanoSynex

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Form D - Notice of Exempt Offering of Securities

QLGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Qualigen Therapeutics Inc (QLGN) Cours

Qualigen Therapeutics Inc (QLGN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Qualigen Therapeutics Inc

QLGN Dernières nouvelles

QLGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités